These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8989123)

  • 1. Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium.
    Hasenfuss G; Mulieri LA; Allen PD; Just H; Alpert NR
    Circulation; 1996 Dec; 94(12):3155-60. PubMed ID: 8989123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium.
    Hasenfuss G; Mulieri LA; Leavitt BJ; Alpert NR
    J Mol Cell Cardiol; 1994 Nov; 26(11):1461-9. PubMed ID: 7897670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium.
    Maier LS; Schwan C; Schillinger W; Minami K; Schütt U; Pieske B
    Cardiovasc Res; 2000 Mar; 45(4):913-24. PubMed ID: 10728417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
    Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
    Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of calcium cycling in nonfailing and failing human myocardium.
    Hasenfuss G; Mulieri LA; Holubarsch C; Pieske B; Just H; Alpert NR
    Basic Res Cardiol; 1992; 87 Suppl 2():81-92. PubMed ID: 1299212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations.
    Hasenfuss G; Holubarsch C; Blanchard EM; Mulieri LA; Alpert NR; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():147-55. PubMed ID: 2818454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.
    Schwinger RH; Böhm M; Erdmann E
    Am Heart J; 1992 Jan; 123(1):116-28. PubMed ID: 1309621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy.
    Hasenfuss G; Mulieri LA; Leavitt BJ; Allen PD; Haeberle JR; Alpert NR
    Circ Res; 1992 Jun; 70(6):1225-32. PubMed ID: 1576741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetic aspects of inotropic interventions in rat myocardium.
    Hasenfuss G; Holubarsch C; Just H; Blanchard E; Mulieri LA; Alpert NR
    Basic Res Cardiol; 1987; 82 Suppl 2():251-9. PubMed ID: 3663019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 May; 15(5):692-7. PubMed ID: 1692927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
    Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
    J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New cardiotonic/inodilator agents: energetic aspects].
    Hasenfuss G
    Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
    Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
    J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response.
    Harding SE; Jones SM; O'Gara P; del Monte F; Vescovo G; Poole-Wilson PA
    J Mol Cell Cardiol; 1992 May; 24(5):549-64. PubMed ID: 1321914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
    Holubarsch C
    Cardiology; 1997; 88 Suppl 2():12-20. PubMed ID: 9142431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A differential inotropic responsiveness to isoprenaline and ouabain in dogs with heart failure.
    Newman WH; Webb JG
    Cardiovasc Res; 1980 Sep; 14(9):530-6. PubMed ID: 7214396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.